BASS XXVIII Tutorials and Keynote Address presentations:

SessionSpeakerPresentation
Keynote AddressRon WassersteinHave we Started Moving to a World Beyond p<0.05?
M-1Vlad Dragalin Complex Innovative Design
M-2Laura Gunn SMART Treatment Decisions: Predicting 10-Year Cardiovascular Event Risks & Assessing Treatment Thresholds in a UK Population
M-3Jose Pinheiro Improving Dose Finding Studies in Drug Development: the MCPMod Approach
M-4Alex Sverdlov Optimal Designs for Clinical Trials: Their Purpose, Utility, and Applications
M-5Mark van der Laan Targeted Learning for Causal Inference Based on Real World Data
T-1Manyun Liu and Roshni Modi Relationship between Overall Survival, Clinical and Genomic data from TCGA's Study on Pancreatic Cancer Patients via Machine Learning
T-2Frank Rockhold Randomized Pragmatic Clinical Trials Utilizing RWD: Myths & Realities
T-3Frank RockholdCOVID Lessons Learnt
T-4Gary Cline Implementing Statistical and Data Science Innovative Approaches in Drug Development
T-5Demissie Alemayehu Challenges and Opportunities with Decentralized Trials: Statistical Perspectives
T-6Fanni Natanegara Decentralized Clinical Trials- Statistical and Data Considerations
T-7Melanie Poulin-CostelloStatistical Considerations in Decentralized Trials
W-1Lei NieStatisticians Face Challenges and Opportunities in Drug Development
W-2Andrew Potter Considerations for Analysis of Data Collected by Wearable Digital Health Technology in Clinical Trials
W-3Satrajit Roychoudhury and Kenneth KouryA Seamless Design to Rapidly Evaluate Vaccine Candidates for COVID-19